Lv11
100 积分 2025-08-04 加入
Randomized, Controlled Trial of the FGF21 Analogue Pegozafermin in NASH
2个月前
已完结
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis
2个月前
已完结
Saroglitazar, a PPAR‐α/γ Agonist, for Treatment of NAFLD : A Randomized Controlled Double‐Blind Phase 2 Trial
2个月前
已完结
CC inhibitor alone or co-administered with a DGAT2 inhibitor in patients with non-alcoholic fatty liver disease: two parallel, placebo-controlled, randomized phase 2a trials
2个月前
已完结
Fibroblast growth factor receptor 1/Klothoβ agonist BFKB8488A improves lipids and liver health markers in patients with diabetes or NAFLD: A phase 1b randomized trial
2个月前
已完结
Phase 1 Trials of PNPLA3 siRNA in I148M Homozygous Patients with MAFLD
2个月前
已完结
Effectiveness and safety of the SREBP1/2 inhibitor, fatostatin, in a preclinical model of metabolic dysfunction-associated steatotic liver disease progression
1年前
已完结
皖公网安备34019202002308
